Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia
Study Information
Alliance Study ID: NCCTG-968151
NCT Study ID (ClinicalTrials.gov): NCT00003255
Disease or Cancer Type: Leukemia & Myelodysplastic Syndromes (MDS)
Alliance Study Chair: Scott H. Kaufmann, MD, PhD
Status: COMPLETED
Study Description
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining carboplatin and topotecan in treating patients with relapsed acute myelogenous leukemia.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information